Autoimmune Encephalitis Due to COVID-19 in a Young Patient
Iranian Journal of Child Neurology,
Vol. 17 No. 2 (2023),
16 Esfand 2023
,
Page 135-142
https://doi.org/10.22037/ijcn.v17i2.38280
Abstract
Autoimmune encephalitis is an inflammatory condition caused by different factors including viral infections that is diagnosed after ruling out other causes of encephalitis. In the current study, we reported a novel case of autoimmune encephalitis in an 11-year-old girl that presented with seizure, cognitive dysfunction and neurological impairments. During the admission, we observed high levels of anti- N-methyl-D-aspartate receptor (NMDAR) antibody in the cerebrospinal fluid (CSF). She had also positive anti COVID-19 IgG. Therefore, the diagnosis of COVID-19 induced autoimmune encephalitis was certain. The patient received anti-epileptic and anti-viral drugs and also IVIG and rituximab and was discharged with remission. The diagnosis of the case was made by anti-NMDAR antibodies that highlights the importance of this diagnostic tool. Similar cases have been reported earlier but the point of this case was her younger age compared to the previous cases and development of neurological deficit before COVID-19 presentations.
- autoimmune encephalitis, COVID-19, infection
How to Cite
References
2. Harutyunyan G, Hauer L, Dünser MW, Karamyan A, Moser T, Pikija S, et al. Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival. Neurocritical care. 2017;27:82-9.
3. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. Journal of child neurology. 2012;27:1460-9.
4. Hermetter C, Fazekas F, Hochmeister S. Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis. Frontiers in neurology. 2018;9:706.
5. Velavan TP, Meyer CG. The COVID‐19 epidemic. Tropical medicine & international health. 2020;25:278.
6. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12.
7. Mulder J, Feresiadou A, Fällmar D, Frithiof R, Virhammar J, Rasmusson A, et al. Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with Covid-19. American Journal of Psychiatry. 2021;178:485-9.
8. Zuhorn F, Omaimen H, Ruprecht B, Stellbrink C, Rauch M, Rogalewski A, et al. Parainfectious encephalitis in COVID-19:“the claustrum sign”. Journal of neurology. 2021;268:2031-4.
9. Dalmau J, Rosenfeld MR, DeAngelis L, Eichler AF. Paraneoplastic and autoimmune encephalitis. UpToDate. 2017.
10. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nature Clinical Practice Neurology. 2007;3:291-6.
11. Gable M, Gavali S, Radner A, Tilley D, Lee B, Dyner L, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. European journal of clinical microbiology & infectious diseases. 2009;28:1421-9.
12. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2009;66:704-9.
13. Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM, et al. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure. 2020;81:18.
14. Zandifar A, Badrfam R. COVID-19 and anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis: Are we facing an increase in the prevalence of autoimmune encephalitis? Journal of Medical Virology. 2021;93:1913-4.
15. Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M, et al. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: a case report. Brain, behavior, and immunity. 2020;87:179.
- Abstract Viewed: 298 times